Eris Lifesciences Ltd

NSE: ERIS · BSE: 540596 · Pharmaceuticals & Biotechnology · 41 announcements

Share price: ₹1,146.30
Market cap: ₹15,904 Cr
Revenue (annual): ₹3,129 Cr
Net profit (annual): ₹619.5 Cr
P/E (TTM): 24.7×Sector 47.4×
Promoter holding: 54.14%+0.22% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7 Employee Stock Options 6 Debt & Borrowing 6 Annual General Meeting 5 Financial Results 4 Management Change 3 Other Announcement 2 Credit Rating 2 Price Movement Clarification 1 Legal & Regulatory 1 Dividend 1 Board Meeting Date 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

12 May 2026 19:13 IST BSE

Credit Rating

Eris Lifesciences Credit Rating

Eris Lifesciences subsidiary received 'IND AA/Stable/IND A1+' ratings for ₹520 Crore banking facilities. The action reflects strong parent linkages and robust operating performance.

Value: ₹520.0 Cr

Read the filing ↗

8 May 2026 17:00 IST BSE

Credit Rating

Eris Lifesciences Credit Rating

India Ratings affirmed Eris Lifesciences Limited's long-term issuer rating at 'IND AA' with a stable outlook. The affirmation covers ₹2,448.00 Crore in NCDs and bank facilities.

Value: ₹2,448 Cr

Read the filing ↗